RespiQ CEO Mira Gleisberg

We are thrilled to announce that respiQ has secured this prestigious €4M Grant alongside our incredible consortium partners Nell-LUMC, Sintef, Kings College London. and uRoboptics

We are proud to announce that respiQ have been awarded a Eurostars grant together with Amsterdam UMC and uRoboptics for our COPDetect project.

What a surprise and honour that respiQ received the LEH subsidy award for our successes in raising (international) grants!

RespiQ CEO Mira Gleisberg featured in Silicon Canals’ Female founders to watch

We have some great news to share today. RespiQ has achieved another major fundraising milestone.

Exciting news: our medtech startup RespiQ is granted early stage financing ‘Vroege Fase Financiering’ (VFF) by The Netherlands Enterprise Agency (RVO)!

RespiQ is proud to join the Dutch research consortium “Precision Medicine for more Oxygen” (P4O2). Part of the research RespiQ joins will focus on lifestyle intervention and personalized nutrition.

We are excited to announce that we are the winners of the innovation awards in the largest investment event in the world: the Annual Investment Meeting - AIM! There was string competition from at least 65 other country winners!

RespiQ receives Digi-B-Cube grant under H2020 program. We were among the top 10% applicants!

In this project, RespiQ will work alongside μRoboptics to improve our technology, automating some of the internal processes of the RespiQ sensor and bringing it closer to market.

RespiQ, one of the 11 funded startups from the first Antler Amsterdam cohort, provides smart breath testing to allow you to make smarter choices to improve your health.

As a well-trained gymnast, Mira Gleisberg, CEO & co-founder of RespiQ, deeply understands the urge of something convenient and effective for wellbeing and early detection.

Vitalii Vorkov, CTO of RespiQ as well as the inventor of the technology, had been excited for this opportunity to work on something that can help millions of people take control of their wellbeing on a daily basis

The Netherlands is the emerging Silicon Valley and has set up a sizzling ground for tech startups. The country is one of the top choices for aspiring entrepreneurs across industries.

RespiQ operates with the mission to leave a positive impact on the health of millions by providing non-invasive, accurate, and affordable technology for early diagnosis of health issues. The company is focused, experienced, and passionate healthtech professionals by developing proven tech, which provides cost-effective and accurate testing at home.

Antler, the global early-stage VC enabling and investing in exceptional entrepreneurs, invests in RespiQ, a medtech innovator in breath analyses for better health. RespiQ is part of their first Amsterdam cohort.